Heart Failure and Structural Heart Disease Department

The Department of Heart Failure and Structural Heart Disease was established in 2002. The department has continued to expand, with continuous improvements in its academic standing and level of medical care. It currently has 41 beds and 5 professors, all of whom hold doctoral degrees and are qualified to supervise master's students; 1 has received a special government allowance.

The department keeps pace with the world's most advanced cutting-edge medical diagnostic and treatment technologies. It primarily treats various acute and critically ill cardiac conditions, including heart failure of various etiologies, hypertension, coronary heart disease, myocardial infarction, cardiomyopathy, myocarditis, pericardial disease, pulmonary hypertension, congenital heart disease, and valvular heart disease. It has successively developed early assessment and chronic disease management for chronic heart failure, treatment of acute and critically ill heart failure, cardiac resynchronization pacemaker therapy (CRT /CRTD) for heart failure, prevention and treatment of sudden death in heart failure and arrhythmias (ICD), interventional diagnosis and treatment of congenital heart disease and valvular heart disease, gene-based precision-medicine diagnosis and treatment of familial hereditary heart disease, and renal replacement therapy (CRRT) for end-stage heart failure complicated by diuretic resistance and refractory hyponatremia.

For many consecutive years, the department has hosted flagship academic conferences such as the “China Heart Failure Forum” and conducted national-level continuing education programs. It has participated in multiple major international clinical trials and established academic exchange relationships with many renowned heart disease centers in China and abroad. The department actively fulfills its social responsibility and is enthusiastic about public welfare activities. It organizes free clinics and health education for “Heart Failure Day,” general screening and charitable treatment for children with congenital heart disease, large public medical science lectures, and consultations and lecture tours in communities and primary-level hospitals. Adhering to the principle of the coordinated development of medical care, education, and research, it currently undertakes 2 National Natural Science Foundation projects and 4 provincial-, municipal-, and university-level projects. Its research achievements have received 6 awards, including the First Prize of the Liaoning Provincial Science and Technology Progress Award and the First Prize of the Dalian Science and Technology Progress Award. It has published more than 200 academic papers and participated in compiling 10 books. The department has achieved fruitful results in its development, and its overall level is advanced within the same field in China.